$15M funding aims to advance stem cell therapies for petsJanuary 8, 2024The financing will go toward achieving the conditional U.S. Food and Drug Administration (FDA) approval of Gallant Therapeutic’s candidate for feline chronic gingivostomatitis
SPONSORED CONTENTWhere unique needs meet innovative scienceFind precise, innovative solutions for your patients' unique needs + Learn More